SEC Form 4 · accession 0001225208-15-008368
BOSTON SCIENTIFIC CORP · BSX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael P. Phalen
Officer — EVP & President, MedSurg
Period of report
Mar 19, 2015
Accepted (ET)
Mar 23, 2015 · 4:05 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000885725
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2,F3 | Mar 19, 2015 | S | 11,085 | $17.7685 | D | 87,981 | D | |
| Common StockF3 | Mar 20, 2015 | M | 35,000 | $12.52 | A | 122,981 | D | |
| Common StockF3 | Mar 20, 2015 | S | 35,000 | $18.00 | D | 87,981 | D | |
| Common StockF4 | holding | — | — | — | 2,433 | I | By 401(k) |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F5,F6 | $12.52 | Mar 20, 2015 | M | 35,000 | D | — | Feb 12, 2018 | Common Stock | 35,000 | 104,773 | D |
Explanation of responses
- F1The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan.
- F2Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $17.7501 to $17.79, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F3Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available.
- F4Balance reflects the most current data available with regard to share holdings through the Boston Scientific Common Stock Fund under the Company's 401(k) Retirement Savings Plan.
- F5Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 12, 2009, the first anniversary of the date of grant.
- F6The Form 3 filed by the reporting person on February 17, 2010 incorrectly reported the expiration date to be December 12, 2018. The expiration date reported on this Form 4 reflects the correct expiration date, which is February 12, 2018.